Pharmaceuticals are working against the clock in search of a vaccine against coronavirus. So, Pfizer was the first to announce that it had developed a remedy with an effectiveness of 90%, although last Wednesday it announced that this value had increased to 95%.
United Kingdom, one of the countries hardest hit by the pandemic, could give regulatory approval for said vaccine this week, even before the United States authorizes it, as The Telegraph newspaper has revealed.
The aforementioned medium, which refers to government sources, states that British regulators are about to begin a formal vaccine evaluation. In addition, according to this information, the National Health Service that was ready to be administered as of December 1.
Request to MHRA
If the news is confirmed, the British country would go ahead in its approval of the United States, which announced Friday that the FDA would meet the next December 10 to discuss the authorization of the vaccine.
Britain last week petitioned its medical regulator, the MHRA, which will evaluate the suitability of the vaccine developed by Pfizer-BioNTech. The country’s authorities have bought 40 million doses and they expect to have at least 10 million vials before the end of the year.